ClouDr Group (HKSE:09955) FCF Margin % : -7.99% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ClouDr Group's Free Cash Flow for the six months ended in Dec. 2023 was HK$-165 Mil. ClouDr Group's Revenue for the six months ended in Dec. 2023 was HK$2,065 Mil. Therefore, ClouDr Group's FCF Margin % for the quarter that ended in Dec. 2023 was -7.99%.

As of today, ClouDr Group's current FCF Yield % is -14.83%.

The historical rank and industry rank for ClouDr Group's FCF Margin % or its related term are showing as below:

HKSE:09955' s FCF Margin % Range Over the Past 10 Years
Min: -69.52 Med: -42.98 Max: -7.14
Current: -7.14

During the past 5 years, the highest FCF Margin % of ClouDr Group was -7.14%. The lowest was -69.52%. And the median was -42.98%.

HKSE:09955's FCF Margin % is ranked worse than
83.51% of 97 companies
in the Medical Distribution industry
Industry Median: 0.95 vs HKSE:09955: -7.14

ClouDr Group FCF Margin % Historical Data

The historical data trend for ClouDr Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group FCF Margin % Chart

ClouDr Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-69.52

-57.08

-42.98

-27.10

-7.14

ClouDr Group Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial			-38.28	-33.61	-21.52	-6.25	-7.99

Competitive Comparison of ClouDr Group's FCF Margin %

For the Medical Distribution subindustry, ClouDr Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ClouDr Group's FCF Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ClouDr Group's FCF Margin % falls into.

ClouDr Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ClouDr Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-288.166	/	4036.63
	=	-7.14 %

ClouDr Group's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-164.943	/	2065.024
	=	-7.99 %

ClouDr Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of ClouDr Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ClouDr Group (HKSE:09955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

H3L:Germany

Address

No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.cloudr.cn

ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

ClouDr Group (HKSE:09955) Headlines

No Headlines